A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
Clinical trial NCT07500506 · RECRUITING
Trial details
- NCT number
- NCT07500506
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-08
- Primary completion
- 2026-12-04
- Enrollment
- 1712
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.